Adelene Q. Perkins
2015
In 2015, Adelene Q. Perkins earned a total compensation of $3.3M as President and Chief Executive Officer at Infinity Pharmaceuticals, a 99% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $130,000 |
|---|---|
| Option Awards | $2,466,550 |
| Salary | $646,865 |
| Other | $9,825 |
| Total | $3,253,240 |
Perkins received $2.5M in option awards, accounting for 76% of the total pay in 2015.
Perkins also received $130K in non-equity incentive plan, $646.9K in salary and $9.8K in other compensation.
Rankings
In 2015, Adelene Q. Perkins' compensation ranked 2,859th out of 13,638 executives tracked by ExecPay. In other words, Perkins earned more than 79.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,859 out of 13,638 | 79th |
Division Manufacturing | 1,010 out of 5,190 | 81st |
Major group Chemicals And Allied Products | 373 out of 1,854 | 80th |
Industry group Drugs | 290 out of 1,528 | 81st |
Industry Pharmaceutical Preparations | 230 out of 1,182 | 81st |
Source: SEC filing on April 25, 2016.
Perkins' colleagues
We found five more compensation records of executives who worked with Adelene Q. Perkins at Infinity Pharmaceuticals in 2015.
2015
Sujay Kango
Infinity Pharmaceuticals
Chief Commercial Officer
2015
Julian Adams
Infinity Pharmaceuticals
President of R&D
2015
Lawrence Bloch
Infinity Pharmaceuticals
Chief Financial Officer
2015
David Roth
Infinity Pharmaceuticals
Chief Medical Officer
2015
Vito Palombella
Infinity Pharmaceuticals